Literature DB >> 3305084

Drug abuse and reproduction.

C G Smith, R H Asch.   

Abstract

It is clear that a number of CNS agents, including drugs of abuse, can inhibit reproductive function. Figure 1 shows the chemical diversity of some of the drug groups that affect reproductive hormones. Their structural dissimilarity to the steroid hormones is also readily apparent in the figure. These chemically diverse drugs share an important pharmacologic property: they are highly potent neuroactive drugs, and they can disrupt hypothalamic-pituitary function. Although it is frequently difficult to distinguish between direct drug actions on the hypothalamic-pituitary axis and subsequent effects on gonadal hormones and sex accessory gland function, the distinction is an important one. Most neuroactive drugs produce only transient effects on the central nervous pathways necessary for normal gonadotropin secretion. The disruptive effects of these drugs are likely to be transient and completely reversible, and tolerance to the inhibitory drug effects may occur even with continued drug use. Under these circumstances, normal adults may experience only subtle changes in sexual function. However, individuals with compromised reproductive function may exhibit major problems. It is also likely that adolescents may be at substantial risk for reproductive damage from these neuroactive drugs since the endocrine events associated with puberty are dependent on the normal development of the hypothalamic-pituitary axis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305084     DOI: 10.1016/s0015-0282(16)59400-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Human immunodeficiency virus/acquired immunodeficiency syndrome and infertility: emerging problems in the era of highly active antiretrovirals.

Authors:  Vitaly A Kushnir; William Lewis
Journal:  Fertil Steril       Date:  2011-06-30       Impact factor: 7.329

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Dietary fat and semen quality among men attending a fertility clinic.

Authors:  Jill A Attaman; Thomas L Toth; Jeremy Furtado; Hannia Campos; Russ Hauser; Jorge E Chavarro
Journal:  Hum Reprod       Date:  2012-03-13       Impact factor: 6.918

4.  MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.

Authors:  Maw Shin Sim; Tomoko Soga; Vijayapandi Pandy; Yuan Seng Wu; Ishwar S Parhar; Zahurin Mohamed
Journal:  Metab Brain Dis       Date:  2017-07-05       Impact factor: 3.584

Review 5.  Epigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in Offspring.

Authors:  Elizabeth E Zumbrun; Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-25       Impact factor: 4.147

6.  Cannabinoid ligand-receptor signaling in the mouse uterus.

Authors:  S K Das; B C Paria; I Chakraborty; S K Dey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  CB1 expression is attenuated in Fallopian tube and decidua of women with ectopic pregnancy.

Authors:  Andrew W Horne; John A Phillips; Nicole Kane; Paula C Lourenco; Sarah E McDonald; Alistair R W Williams; Carlos Simon; Sudhansu K Dey; Hilary O D Critchley
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.